Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsSUBCUTANEOUSStandard

GVOKE HYPOPEN

GLUCAGON

Standard Dose
0.5MG/0.1ML (0.5MG/0.1ML)
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Prescription
Summary

Approval overview GVOKE HYPOPEN is listed in Drugs@FDA under application 212097 (NDA).

Review priority: STANDARD Marketing status: Prescription Active ingredient GLUCAGON Form and strength SOLUTION;SUBCUTANEOUS - 0.5MG/0.1ML (0.5MG/0.1ML) Sponsor XERIS Submission history Latest submission status date: 2025-03-14 00:00:00.

Structured Monograph

Clinical summary

Approval overview GVOKE HYPOPEN is listed in Drugs@FDA under application 212097 (NDA). Review priority: STANDARD Marketing status: Prescription Active ingredient GLUCAGON Form and strength SOLUTION;SUBCUTANEOUS - 0.5MG/0.1ML (0.5MG/0.1ML) Sponsor XERIS Submission history Latest submission status date: 2025-03-14 00:00:00. Submission type: SUPPL.

Monitoring

  • • Marketing status: Prescription
  • • Review priority: STANDARD

Interaction Notes

  • No interaction notes stored yet.
GVOKE HYPOPEN (GLUCAGON) | Drug Monograph | MedicHelpline